The multicentric CIBIS–ELD trial compares two different pharmacological beta-blockers in elderly patients with chronic heart failure.
The CIBIS–ELD trial compares two different pharmacological beta-blockers, Bisoprolol and Carvedilol in elderly patients with chronic heart failure. In a typical heart failure collective, the highly selective betablocker Bisoprolol is compared to the non-selective alpha and betablocker Carvedilol in terms of therapeutic efficacy and tolerability.
Multicentric, multinational, randomized, double-blind, double-dummy trial
Beta-blocker naïve 65 year-old patients (or older) with medium to acute diastolic or systolic chronic heart failure.
Patients enrolled in study
55 centers in four countries (Germany, Serbia, Montenegro and Slovenia)